Status:
COMPLETED
A New Risk Score for the Emergency Department in Patients with Upper Gastrointestinal Bleeding
Lead Sponsor:
Sakarya University
Conditions:
Upper Gastrointestinal Bleeding (UGIB)
Emergency Department Patient
Eligibility:
All Genders
18+ years
Brief Summary
Abstract Background: The aim of this study was to develop a simpler, more practical, and highly effective risk scoring system for patients presenting to the emergency department with upper gastrointes...
Eligibility Criteria
Inclusion
- Patients aged over 18 years who presented to the ED with UGIB symptoms and signs (hematemesis, melena, and hematochezia) and were hospitalized between January 1, 2022, and June 1, 2023, were included in the study.
Exclusion
- Patients with insufficient data, lower gastrointestinal bleeding, or those who did not undergo endoscopy due to death, refusal of treatment, or symptom resolution were excluded.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
589 Patients enrolled
Trial Details
Trial ID
NCT06878183
Start Date
January 1 2022
End Date
June 1 2023
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sakarya Training and Research Hospital
Sakarya, Adapazarı, Turkey (Türkiye), 54100